| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
PAPER |
1 Department of Neurology, University Medical Centre Nijmegen, Netherlands
2 Alzheimer Centre and Department of Neurology, VU Medical Centre, Amsterdam, Netherlands
3 Department of Radiology, VU Medical Centre, Amsterdam
Correspondence to:
Correspondence to:
Professor Philip Scheltens
Alzheimer Centre, Department of Neurology, VU Medical Centre, PO Box 7057, 1007MB Amsterdam, Netherlands; p.scheltens{at}vumc.nl
Background: Vascular risk factors could play a role in the aetiology of Alzheimer’s disease, but this has not been investigated in relation to neuroimaging findings
Objective: To evaluate the distribution of blood pressure and an indicator of atherosclerosis (pulse pressure) in patients with Alzheimer’s disease with and without small vessel disease.
Methods: 152 Alzheimer patients underwent 1.0T MRI scanning. Blood pressure was measured with a sphygmomanometer. Small vessel disease was assessed by the presence of lacunar infarcts and white matter lesions. The distribution of blood pressure and pulse pressure, with or without small vessel disease, was assessed by linear regression analysis.
Results: Patients with small vessel disease had a higher blood pressure, a wider pulse pressure, and an increased prevalence of hypertension. These findings were strongly age dependent: for patients under 65, mean systolic blood pressure was higher in the subpopulation with small vessel disease than in those without (mean (SD): 149.9 (19.3) v 135.7 (20.5) mm Hg; p = 0.02). Hypertension was more common in patients with white matter lesions than in those without (75.6% v 45.1%; p = 0.03) and the pulse pressure was higher (61.9 (14.4) v 51.7 (11.5) mm Hg; p = 0.01). There was no relation between blood pressure and the degree of (sub)cortical and hippocampal atrophy in patients without small vessel disease.
Conclusions: There was heterogeneity in Alzheimer’s disease patients with respect to blood pressure and pulse pressure. Alzheimer’s disease encompasses a heterogeneous group of disorders which share a common cognitive profile but with distinct radiological features with respect to white matter lesions.
Abbreviations: MMSE, mini-mental state examination; MTA, medial temporal lobe atrophy; NINCDS–ADRDA, National Institute of Neurological and Communicative Disorders and Stroke and Alzheimer’s disease and Related Disorders Association
Keywords: Alzheimer’s disease; blood pressure; white matter; magnetic resonance imaging
This article has been cited by other articles:
|
|
 |
|
  S. Galluzzi, C. Geroldi, L. Benussi, R. Ghidoni, C. Testa, G. Borsci, M. Bonetti, D. Manfellotto, G. Romanelli, R. Zulli, et al. Association of Blood Pressure and Genetic Background With White Matter Lesions in Patients With Mild Cognitive Impairment J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 510 - 517. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Stopa, P. Butala, S. Salloway, C. E. Johanson, L. Gonzalez, R. Tavares, V. Hovanesian, C. M. Hulette, M. P. Vitek, and R. A. Cohen Cerebral Cortical Arteriolar Angiopathy, Vascular Beta-Amyloid, Smooth Muscle Actin, Braak Stage, and APOE Genotype Stroke, March 1, 2008; 39(3): 814 - 821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S MILLS, J CAIN, N PURANDARE, and A JACKSON Biomarkers of cerebrovascular disease in dementia Br. J. Radiol., December 1, 2007; 80(Special_Issue_2): S128 - S145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Behl, C. Bocti, R. H. Swartz, F. Gao, D. J. Sahlas, K. L. Lanctot, D. L. Streiner, and S. E. Black Strategic Subcortical Hyperintensities in Cholinergic Pathways and Executive Function Decline in Treated Alzheimer Patients Arch Neurol, February 1, 2007; 64(2): 266 - 272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Stam, B. Jones, G Nolte, M Breakspear, and P. Scheltens Small-World Networks and Functional Connectivity in Alzheimer's Disease Cereb Cortex, January 1, 2007; 17(1): 92 - 99. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Regan, C. Katona, Z. Walker, J. Hooper, J. Donovan, and G. Livingston Relationship of vascular risk to the progression of Alzheimer disease Neurology, October 24, 2006; 67(8): 1357 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Peters Ageing and the brain Postgrad. Med. J., February 1, 2006; 82(964): 84 - 88. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. M. Olde Rikkert, W. M. van der Flier, F. E. deLeeuw, M. Verbeek, R. W. M. M. Jansen, F. Verhey, and P. Scheltens Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia Arch Neurol, January 1, 2006; 63(1): 144 - 146. [Full Text] [PDF]
|
|
|
|
 |
|
 F-E de Leeuw Lipid lowering agents to delay cognitive decline in Alzheimer's disease? J. Neurol. Neurosurg. Psychiatry, December 1, 2005; 76(12): 1611 - 1613. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
